{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:15Z","timestamp":1790742015308,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s11154-016-9328-5","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T03:52:32Z","timestamp":1454298752000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":202,"title":["Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa"],"prefix":"10.1007","volume":"17","author":[{"given":"Wayne","family":"Gulliver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol","family":"Prens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor B. E.","family":"Jemec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thrasivoulos","family":"Tzellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,1]]},"reference":[{"key":"9328_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12966","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015. doi: 10.1111\/jdv.12966 .","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9328_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/derm.2.1.12490","volume":"2","author":"S Fimmel","year":"2010","unstructured":"Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010;2:9\u201316.","journal-title":"Dermatoendocrinol"},{"key":"9328_CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","volume":"17","author":"H Kurzen","year":"2008","unstructured":"Kurzen H, Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455\u201372.","journal-title":"Exp Dermatol"},{"key":"9328_CR4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","volume":"144","author":"JM Werth Von der","year":"2010","unstructured":"Von der Werth JM, Jemec GBE. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2010;144:809\u201313.","journal-title":"Br J Dermatol"},{"key":"9328_CR5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaad.2012.07.027","volume":"68","author":"I Cosmatos","year":"2013","unstructured":"Cosmatos I, Matcho A, Weinstein R, et al. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;68:412\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"9328_CR6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59:596\u2013601.","journal-title":"J Am Acad Dermatol"},{"key":"9328_CR7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","volume":"35","author":"GB Jemec","year":"1996","unstructured":"Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35:191\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"9328_CR8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.1988.tb03227.x","volume":"119","author":"GB Jemec","year":"1988","unstructured":"Jemec GB. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol. 1988;119:345\u201350.","journal-title":"Br J Dermatol"},{"key":"9328_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","volume":"133","author":"BG Vazquez","year":"2013","unstructured":"Vazquez BG, Alikhan A, Weaver AL, et al. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted county, Minnesota. J Invest Dermatol. 2013;133:97\u2013103.","journal-title":"J Invest Dermatol"},{"key":"9328_CR10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2230.2001.00876.x","volume":"26","author":"RA Palmer","year":"2001","unstructured":"Palmer RA, Keefe M. Early-onset hidradenitis suppurativa. Clin Exp Dermatol. 2001;26:501\u20133.","journal-title":"Clin Exp Dermatol"},{"key":"9328_CR11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaad.2014.11.017","volume":"72","author":"IE Deckers","year":"2015","unstructured":"Deckers IE, van der Zee HH, Boer J, Prens EP. Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement. J Am Acad Dermatol. 2015;72:485\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"9328_CR12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40272-014-0091-3","volume":"16","author":"PR Mikkelsen","year":"2014","unstructured":"Mikkelsen PR, Jemec GB. Hidradenitis suppurativa in children and adolescents: a review of treatment options. Paediatr Drugs. 2014;16:483\u20139.","journal-title":"Paediatr Drugs"},{"key":"9328_CR13","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","volume":"149","author":"HK Randhawa","year":"2013","unstructured":"Randhawa HK, Hamilton J, Pope E. Finasteride for the treatment of hidradenitis suppurativa in children and adolescents. JAMA Dermatol. 2013;149:732\u20135.","journal-title":"JAMA Dermatol"},{"key":"9328_CR14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jss.2013.05.056","volume":"184","author":"RM Rentea","year":"2013","unstructured":"Rentea RM, Somers KK, Cassidy L, Enters J, Arca MJ. Negative pressure wound therapy in infants and children: a single-institution experience. J Surg Res. 2013;184:658\u201364.","journal-title":"J Surg Res"},{"key":"9328_CR15","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bjd.13270","volume":"171","author":"AB Kimball","year":"2014","unstructured":"Kimball AB, Jemec GBE, et al. Assessing the validity, responsiveness and meaningfulness of the hidradenitis suppurativa clinical response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. Br J Dermatol. 2014;171:1434\u201342.","journal-title":"Br J Dermatol"},{"key":"9328_CR16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"G Guyatt","year":"2008","unstructured":"Guyatt G, Oxman AD, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ April. 2008;336:924 Last accessed February 2014.","journal-title":"BMJ April"},{"key":"9328_CR17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","volume":"22","author":"OJ Clemmensen","year":"1983","unstructured":"Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22:325\u20138.","journal-title":"Int J Dermatol"},{"key":"9328_CR18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","volume":"39","author":"GB Jemec","year":"1998","unstructured":"Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39:971\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"9328_CR19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","volume":"219","author":"G Gener","year":"2009","unstructured":"Gener G, Canoui-Poitrine F, Revuz JE, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009;219:148\u201354.","journal-title":"Dermatology"},{"key":"9328_CR20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","volume":"157","author":"AB Kimball","year":"2012","unstructured":"Kimball AB, Kerdel F, Adams D, et al. Adalimumab for the treatment of moderate to severe hidradenitissuppurativa: a parallel randomized trial. Ann Intern Med. 2012;157:846\u201355.","journal-title":"Ann Intern Med"},{"key":"9328_CR21","unstructured":"Jemec GBE 2014 Efficacy and Safety of Adalimumab in Patients with Moderate to Severe Hidradenitis Suppurativa: Results from PIONEER II, a Phase 3, Randomized, Placebo-Controlled Trial. Abstract FC08.2. 22nd Congress of the European Dermatology and Venereology (EADV) Meeting, Amsterdam, Netherlands"},{"key":"9328_CR22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","volume":"62","author":"A Grant","year":"2010","unstructured":"Grant A, Gonzalez T, Montgomery MO, et al. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62:205\u201317.","journal-title":"J Am Acad Dermatol"},{"key":"9328_CR23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archdermatol.2011.1950","volume":"148","author":"PV Rambhatla","year":"2012","unstructured":"Rambhatla PV, Lim HW, Hamzavi I. A systematic review of treatments for hidradenitis suppurativa. Arch Dermatol. 2012;148:439\u201346.","journal-title":"Arch Dermatol"},{"key":"9328_CR24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00042728-200802000-00012","volume":"34","author":"MG Buimer","year":"2008","unstructured":"Buimer MG, Ankersmit MF, Wobbes T, et al. Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol Surg. 2008;34:224\u20137.","journal-title":"Dermatol Surg"},{"key":"9328_CR25","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1524-4725.2010.01763.x","volume":"36","author":"A Bieniek","year":"2010","unstructured":"Bieniek A, Matusiak L, Okulewicz-Gojlik D, Szepietowski JC. Surgical treatment of hidradenitis suppurativa: experiences and recommendations. Dermatol Surg. 2010;36:1998\u20132004.","journal-title":"Dermatol Surg"},{"key":"9328_CR26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/028443101750523230","volume":"35","author":"J Bohn","year":"2001","unstructured":"Bohn J, Svensson H. Surgical treatment of hidradenitis suppurativa. Scand J PlastReconstr Surg Hand Surg. 2001;35:305\u20139.","journal-title":"Scand J PlastReconstr Surg Hand Surg"},{"key":"9328_CR27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1468-3083.2011.04203.x","volume":"26","author":"DC Rappard van","year":"2012","unstructured":"van Rappard DC, Mooij JE, Mekkes JR. Mild to moderate hidradenitis suppurativa treated with local excision and primary closure. J Eur Acad Dermatol Venereol. 2012;26:898\u2013902.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9328_CR28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","volume":"26","author":"R Rompel","year":"2000","unstructured":"Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg. 2000;26:638\u201343.","journal-title":"Dermatol Surg"},{"key":"9328_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-5945-12-9","volume":"12","author":"Z Alharbi","year":"2012","unstructured":"Alharbi Z, Kauczok J, Pallua N. A review of wide surgical excision of hidradenitis suppurativa. BMC Dermatol. 2012;12:9.","journal-title":"BMC Dermatol"},{"key":"9328_CR30","doi-asserted-by":"crossref","first-page":"370e","DOI":"10.1097\/PRS.0000000000000080","volume":"133","author":"YE Chen","year":"2014","unstructured":"Chen YE, Gerstle T, Verma K, Treiser MD, Kimball AB, Orgill DP. Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device. Plast Reconst Surg. 2014;133:370e.","journal-title":"Plast Reconst Surg"},{"key":"9328_CR31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1468-3083.2012.04646.x","volume":"27","author":"A Bieniek","year":"2013","unstructured":"Bieniek A, Matusiak L, Chlebicka I, et al. Secondary intention healing in skin surgery: our own experience and expanded indications in hidradenitis suppurativa, rhinophyma and non-melanoma skin cancers. J Eur Acad Dermatol Venereol. 2013;27:1015\u201321.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9328_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1479-666X(05)80006-X","volume":"3","author":"A Mandal","year":"2005","unstructured":"Mandal A, Watson J. Experience with different treatment modules in hidradenitis suppuritiva: a study of 106 cases. Surgeon. 2005;3:23\u20136.","journal-title":"Surgeon"},{"key":"9328_CR33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s003840050159","volume":"13","author":"JP Ritz","year":"1998","unstructured":"Ritz JP, Runkel N, Haier J, Buhr HJ. Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Color Dis. 1998;13:164\u20138.","journal-title":"Int J Color Dis"},{"key":"9328_CR34","doi-asserted-by":"crossref","unstructured":"Wiltz O, Schoetz Jr DJ, Murray JJ, Roberts PL, Coller JA, Veidenheimer MC. Perianal hidradenitis suppurativa: the lahey clinic experience. Dis Colon rectum. 1990;33:731\u20134.","DOI":"10.1007\/BF02052316"},{"key":"9328_CR35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jaad.2009.12.018","volume":"63","author":"HH Zee van der","year":"2010","unstructured":"van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am AcadDermatol. 2010;63:475\u201380.","journal-title":"J Am AcadDermatol"},{"key":"9328_CR36","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/jdv.12952","volume":"29","author":"JL Blok","year":"2015","unstructured":"Blok JL, Boersma M, Terra JB, et al. Surgery under general anaesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients. J Eur Acad Dermatol Venereol. 2015;29:1590\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9328_CR37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1524-4725.2009.01427.x","volume":"36","author":"PG Hazen","year":"2010","unstructured":"Hazen PG, Hazen BP. Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg. 2010;36:208\u201313.","journal-title":"Dermatol Surg"},{"key":"9328_CR38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1067\/mjd.2002.124601","volume":"47","author":"J Lapins","year":"2002","unstructured":"Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol. 2002;47:280\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"9328_CR39","doi-asserted-by":"crossref","unstructured":"Mikkelsen PR, Dufour DN, Zarchi K, et al. Recurrence rate and patient satisfaction of CO2 laser evapration of lesions in patients with hidradenitis suppurativa: a retrospective study. Dermatol Surg. 2015;41(2):255\u201360.","DOI":"10.1097\/DSS.0000000000000264"},{"key":"9328_CR40","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1524-4725.2009.01214.x","volume":"35","author":"E Tierney","year":"2009","unstructured":"Tierney E, Mahmoud BH, Hexsel C, et al. Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2009;35:1188\u201398.","journal-title":"Dermatol Surg"},{"key":"9328_CR41","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2009.07.048","volume":"62","author":"BH Mahmoud","year":"2010","unstructured":"Mahmoud BH, Tierney E, Hexsel CL, et al. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium: yttrium-aluminum-garnet laser. J Am Acad Dermatol. 2010;62:637\u201345.","journal-title":"J Am Acad Dermatol"},{"key":"9328_CR42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/PRS.0b013e31821e6fb5","volume":"128","author":"L Highton","year":"2011","unstructured":"Highton L, Chan W-Y, Khwaja N, Laitung JKG. Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study. Plast Reconstr Surg. 2011;128:459\u201365.","journal-title":"Plast Reconstr Surg"},{"key":"9328_CR43","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","volume":"66","author":"SHJ AndrewsJC","year":"2013","unstructured":"AndrewsJC SHJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation\u2019s direction and strength. J Clin Epidemiol. 2013;66:726\u201335.","journal-title":"J Clin Epidemiol"},{"key":"9328_CR44","unstructured":"FDA. Structured Approach to Benefit-Risk Assessment in Drug Regulatory Decision-Making. Available at: http:\/\/www.fda.gov\/downloads\/ForIndustry\/UserFees\/PrescriptionDrugUserFee\/UCM329758.pdf . Last accessed December 2014."},{"key":"9328_CR45","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bjd.13270","volume":"171","author":"AB Kimball","year":"2014","unstructured":"Kimball AB, Jemec GEB, Yang M, et al. Assessing the validity, responsiveness and meaningfulness of the hidradenitis suppurativa clinical response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. Br J Dermatol. 2014;171:1434\u201342.","journal-title":"Br J Dermatol"},{"key":"9328_CR46","unstructured":"Kimball AB, Jemec GEB, Gu Y, Williams DA. 2013 A Novel Hidradenitis Suppurativa Efficacy Variable, HiSCR (Hidradenitis Suppurativa Clinical Response), Is Responsive to Change With Adalimumab Therapy: Results of a Phase 2 Study. Presented at the 71st Annual Meeting of the American Academy of Dermatology in Miami Beach, FL, USA, March 1\u20135, p 6661"},{"key":"9328_CR47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","volume":"29","author":"E Shavit","year":"2015","unstructured":"Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29:371\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9328_CR48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","volume":"67","author":"A Kurek","year":"2012","unstructured":"Kurek A, Peters EM, Chanwangpong A, Sabat R, Sterry W, Schneider-Burrus S. Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol. 2012;67:422\u20138.","journal-title":"J Am Acad Dermatol"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9328-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-016-9328-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9328-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9328-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:51:33Z","timestamp":1567558293000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-016-9328-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9328"],"URL":"https:\/\/doi.org\/10.1007\/s11154-016-9328-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727817111.793534548","asserted-by":"object"}]},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,1]]}}}